Literature DB >> 34523743

Conductive Hearing Loss in the Hyp Mouse Model of X-Linked Hypophosphatemia Is Accompanied by Hypomineralization of the Auditory Ossicles.

Maximilian M Delsmann1,2, Richard Seist3,4, Julian Stürznickel1,2, Felix N Schmidt1, Amer Mansour3, Margaret M Kobelski5, Gabriel Broocks6, Jonathan Peichl7, Ralf Oheim1, Mark Praetorius7, Thorsten Schinke1, Michael Amling1, Marie B Demay5, Konstantina M Stankovic3,4, Tim Rolvien2.   

Abstract

X-linked hypophosphatemia (XLH) is a hereditary musculoskeletal disorder caused by loss-of-function mutations in the PHEX gene. In XLH, increased circulating fibroblast growth factor 23 (FGF23) levels cause renal phosphate wasting and low concentrations of 1,25-dihydroxyvitamin D, leading to an early clinical manifestation of rickets. Importantly, hearing loss is commonly observed in XLH patients. We present here data from two XLH patients with marked conductive hearing loss. To decipher the underlying pathophysiology of hearing loss in XLH, we utilized the Hyp mouse model of XLH and measured auditory brain stem responses (ABRs) and distortion product otoacoustic emissions (DPOAEs) to functionally assess hearing. As evidenced by the increased ABR/DPOAE threshold shifts in the mid-frequency range, these measurements indicated a predominantly conductive hearing loss in Hyp mice compared to wild-type (WT) mice. Therefore, we carried out an in-depth histomorphometric and scanning electron microscopic analysis of the auditory ossicles. Quantitative backscattered electron imaging (qBEI) indicated a severe hypomineralization of the ossicles in Hyp mice, evidenced by lower calcium content (CaMean) and higher void volume (ie, porosity) compared to WT mice. Histologically, voids correlated with unmineralized bone (ie, osteoid), and the osteoid volume per bone volume (OV/BV) was markedly higher in Hyp mice than WT mice. The density of osteocyte lacunae was lower in Hyp mice than in WT mice, whereas osteocyte lacunae were enlarged. Taken together, our findings highlight the importance of ossicular mineralization for hearing conduction and point toward the potential benefit of improving mineralization to prevent hearing loss in XLH.
© 2021 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). © 2021 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

Entities:  

Keywords:  ANIMAL MODELS; BONE MATRIX; CELL/TISSUE SIGNALING - ENDOCRINE PATHWAYS; GENETIC ANIMAL MODELS; MATRIX MINERALIZATION; PTH/Vit D/FGF23

Mesh:

Substances:

Year:  2021        PMID: 34523743      PMCID: PMC8688200          DOI: 10.1002/jbmr.4443

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  54 in total

1.  Decrease in the osteocyte lacunar density accompanied by hypermineralized lacunar occlusion reveals failure and delay of remodeling in aged human bone.

Authors:  Björn Busse; Danijela Djonic; Petar Milovanovic; Michael Hahn; Klaus Püschel; Robert O Ritchie; Marija Djuric; Michael Amling
Journal:  Aging Cell       Date:  2010-10-28       Impact factor: 9.304

2.  Vitamin D regulates osteocyte survival and perilacunar remodeling in human and murine bone.

Authors:  Tim Rolvien; Matthias Krause; Anke Jeschke; Timur Yorgan; Klaus Püschel; Thorsten Schinke; Björn Busse; Marie B Demay; Michael Amling
Journal:  Bone       Date:  2017-06-27       Impact factor: 4.398

3.  Impaired hearing in X-linked hypophosphataemic (vitamin-D-resistant) osteomalacia.

Authors:  M Davies; R Kane; J Valentine
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

4.  Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia.

Authors:  Cong Zhang; Zhen Zhao; Yue Sun; Lijun Xu; Ruizhi JiaJue; Lijia Cui; Qianqian Pang; Yan Jiang; Mei Li; Ou Wang; Xiaodong He; Shuli He; Min Nie; Xiaoping Xing; Xunwu Meng; Xueying Zhou; Lina Yan; Jared M Kaplan; Karl L Insogna; Weibo Xia
Journal:  Bone       Date:  2019-01-23       Impact factor: 4.398

5.  Alterations of bone material properties in adult patients with X-linked hypophosphatemia (XLH).

Authors:  Nadja Fratzl-Zelman; Sonja Gamsjaeger; Stéphane Blouin; Roland Kocijan; Pia Plasenzotti; Stamatia Rokidi; Kamilla Nawrot-Wawrzyniak; Katharina Roetzer; Gökhan Uyanik; Gabriele Haeusler; Elizabeth Shane; Adi Cohen; Klaus Klaushofer; Eleftherios P Paschalis; Paul Roschger; Peter Fratzl; Jochen Zwerina; Elisabeth Zwettler
Journal:  J Struct Biol       Date:  2020-06-30       Impact factor: 2.867

Review 6.  An Overview of Rickets in Children.

Authors:  Rahul Chanchlani; Paul Nemer; Rajiv Sinha; Lena Nemer; Vinod Krishnappa; Etienne Sochett; Fayez Safadi; Rupesh Raina
Journal:  Kidney Int Rep       Date:  2020-04-11

7.  Early bone tissue aging in human auditory ossicles is accompanied by excessive hypermineralization, osteocyte death and micropetrosis.

Authors:  Tim Rolvien; Felix N Schmidt; Petar Milovanovic; Katharina Jähn; Christoph Riedel; Sebastian Butscheidt; Klaus Püschel; Anke Jeschke; Michael Amling; Björn Busse
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

8.  Characterization of otologic involvement in patients with X-Linked Hypophosphatemia.

Authors:  Danisa Ivanovic-Zuvic; María Jesús Santander; Macarena Jiménez; Iván Novoa; Matías Winter; Pablo Florenzano
Journal:  Clin Otolaryngol       Date:  2021-07-29       Impact factor: 2.597

Review 9.  Significant association between osteoporosis and hearing loss: a systematic review and meta-analysis.

Authors:  Sikarin Upala; Pattara Rattanawong; Wasawat Vutthikraivit; Anawin Sanguankeo
Journal:  Braz J Otorhinolaryngol       Date:  2016-09-12
View more
  1 in total

1.  Prevention of Hypomineralization In Auditory Ossicles of Vitamin D Receptor (Vdr) Deficient Mice.

Authors:  Maximilian M Delsmann; Jonathan Peichl; Timur A Yorgan; Frank Timo Beil; Michael Amling; Marie B Demay; Tim Rolvien
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-06       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.